← Eichor
Condition: Targeted Therapy Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Targeted Therapy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Improving Therapeutic Drug Monitoring and Dosing for Vancomycin in Young Infants With Infections (VANCAPP) (Part 2)
Phase 4 · 4 location(s) · Murdoch Childrens Research Institute · NCT05770622Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors
Phase 1/Phase 2 · 11 location(s) · National Health Research Institutes, Taiwan · NCT05048901A Prospective, Multicenter, Single-arm Study to Evaluate a Transcatheter Aortic Valve System Safety and Efficacy for the
NA · 1 location(s) · Pan Xiangbin · NCT06136429A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer
Phase 4 · 8 location(s) · Fudan University · NCT06195228Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells
Phase 1 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT06305299Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy
EARLY_Phase 1 · 1 location(s) · Vanderbilt-Ingram Cancer Center · NCT06828588Anti-GD2 ADC M3554 in Advanced Solid Tumors
Phase 1 · 11 location(s) · EMD Serono Research & Development Institute, Inc. · NCT06641908NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Ca
Phase 3 · 1 location(s) · Shanghai Zhongshan Hospital · NCT07309289[177Lu]Lu-DOTA-EB-RGD2 Therapy in Patients With Recurrent High-grade Glioma
EARLY_Phase 1 · 2 location(s) · Beijing Tiantan Hospital · NCT07655869Zn-DDC to Target Hypoxia-NFkappaB-CSCs Pathway in Multiple Myeloma
Phase N/A · 1 location(s) · The Royal Wolverhampton Hospitals NHS Trust · NCT04234022Polymer-lipid Particle-delivered CAR1920 mRNA CAR-T Therapy for Relapsed/Refractory B-cell Lymphoma/Leukemia
Phase 2 · 1 location(s) · Daihong Liu · NCT07321301APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Ther
Phase N/A · 1 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT05550961In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies
Phase 1 · 1 location(s) · Chongqing Precision Biotech Co., Ltd · NCT07239323Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05616650An Exploratory Study by Fast CAR T Cells
EARLY_Phase 1 · 1 location(s) · Shanghai Cell Therapy Group Co.,Ltd · NCT06327997Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT06840262Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
Phase 1 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT05366179Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression
Phase 4 · 1 location(s) · Laureate Institute for Brain Research, Inc. · NCT06004115A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of Advanced Solid Tumor
NA · 1 location(s) · Fudan University · NCT06682117Prognosis Stratification for Advanced HCC Receiving TACE with PD-1/PD-L1 Inhibitors and Molecular Target Therapies
Phase N/A · 1 location(s) · Zhongda Hospital · NCT06607120Effect of Additional Sural Nerve PRF in Chronic Heel Pain
Phase N/A · 1 location(s) · Diskapi Teaching and Research Hospital · NCT07383558Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
Phase 1 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT06347068The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer
Phase 2 · 1 location(s) · Fudan University · NCT05628038The Effect of Survival, Response and Microbiota Change in Different Therapy Under Probiotic Supplement
NA · 1 location(s) · Chang Gung Memorial Hospital · NCT06998823UCAR T-cell Therapy Targeting CD19/BCMA in Relapsed/Refractory Autoimmune Hemolytic Anemia
EARLY_Phase 1 · 1 location(s) · The Second Hospital of Anhui Medical University · NCT07530380Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma
Phase 1/Phase 2 · 1 location(s) · Beijing Biotech · NCT07510815Exploratory Study on mRNA Therapeutic Drug Targeting CD19 for the Treatment of Hematologic Malignancies
EARLY_Phase 1 · 1 location(s) · Xinqiao Hospital of Chongqing · NCT07349849Impact of Using the Oncogramme® Device to Select the First Line of Treatment for Patients With Metastatic Colorectal Can
NA · 1 location(s) · Oncomedics · NCT05299840Drug Survival of Target Therapies in Atopic Dermatitis
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06882148Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries
Phase 2/Phase 3 · 1 location(s) · Stanford University · NCT06424834
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.